Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation TCT 2024

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

TCT 641: Time to Treatment for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 29, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation ESC 2024

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Presenter: Hélène Eltchaninoff

August 31, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

Using temporary permanent pacemaker as a one-month bridge after TAVI

Presenter: Guangyuan Song

May 14, 2024

Presentation EuroPCR 2024

Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial

Presenter: Roxana Mehran

May 14, 2024

Presentation EuroPCR 2024

Short Methodology Insight - NOTION-2

Presenter: Davide Capodanno

May 14, 2024

Presentation EuroPCR 2024

Short Methodology Insight - LANDMARK

Presenter: Davide Capodanno

May 14, 2024

Presentation EuroPCR 2024

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

Presenter: Giuliano Costa

May 14, 2024

Presentation EuroPCR 2024

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Presenter: Hans-Josef Feistritzer

May 14, 2024

Presentation ACC 2024

Self-Expanding Versus Balloon-Expandable TAVR in Patients with Aortic Stenosis and Small Aortic Annuli

Presenter: Howard C. Herrmann

April 07, 2024

Presentation THT Abstracts 2024

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Presenter: Antoon van den Enden

March 05, 2024

Advertisement

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

TCT 641: Time to Treatment for Severe Aortic Stenosis in a Large Community-based Health Care System

The EARLY TAVR Trial Editorial Commentary

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Continuation versus Interruption of Oral Anticoagulation during TAVI

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Using temporary permanent pacemaker as a one-month bridge after TAVI

Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial

Short Methodology Insight - NOTION-2

Short Methodology Insight - LANDMARK

Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study

Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial

Self-Expanding Versus Balloon-Expandable TAVR in Patients with Aortic Stenosis and Small Aortic Annuli

Appreciating the immediate changes in left ventricular cardiomechanics after transcatheter aortic valve replacement for moderate aortic stenosis: a case series

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content